Our present study, which enrolled patients with STEMI, demonstrated for the first time that BAFF could augment conventional risk stratification models in patients with STEMI, which may further contribute to the participation of BAFF in human myocardial infarction and its progression. Here, TNFSF13B is linked to myocardial infarction.